Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 21

1.

Signal transducer and activator of transcription 3 is required for abnormal proliferation and survival of TSC2-deficient cells: relevance to pulmonary lymphangioleiomyomatosis.

Goncharova EA, Goncharov DA, Damera G, Tliba O, Amrani Y, Panettieri RA Jr, Krymskaya VP.

Mol Pharmacol. 2009 Oct;76(4):766-77. doi: 10.1124/mol.109.057042. Epub 2009 Jul 13.

2.

Smooth muscle-like cells in pulmonary lymphangioleiomyomatosis.

Krymskaya VP.

Proc Am Thorac Soc. 2008 Jan 1;5(1):119-26. Review.

3.

Pulmonary lymphangioleiomyomatosis (LAM): progress and current challenges.

Goncharova EA, Krymskaya VP.

J Cell Biochem. 2008 Feb 1;103(2):369-82. Review.

PMID:
17541983
4.

Mammalian target of rapamycin signaling and autophagy: roles in lymphangioleiomyomatosis therapy.

Yu J, Parkhitko AA, Henske EP.

Proc Am Thorac Soc. 2010 Feb;7(1):48-53. doi: 10.1513/pats.200909-104JS. Review.

5.

Clinical and molecular insights into lymphangioleiomyomatosis.

Steagall WK, Taveira-DaSilva AM, Moss J.

Sarcoidosis Vasc Diffuse Lung Dis. 2005 Dec;22 Suppl 1:S49-66. Review.

PMID:
16457017
6.
7.

[Current understanding and perspectives of lymphangioleiomyomatosis].

Seyama K, Ando K, Hoshika Y, Suzuki Y, Takekawa H.

Nihon Rinsho. 2013 Jun;71(6):1103-8. Review. Japanese.

PMID:
23855221
8.

LAM cells biology and lymphangioleiomyomatosis.

Grzegorek I, Drozdz K, Podhorska-Okolow M, Szuba A, Dziegiel P.

Folia Histochem Cytobiol. 2013;51(1):1-10. doi: 10.5603/FHC.2013.001. Review.

9.

Clinical features, epidemiology, and therapy of lymphangioleiomyomatosis.

Taveira-DaSilva AM, Moss J.

Clin Epidemiol. 2015 Apr 7;7:249-57. doi: 10.2147/CLEP.S50780. eCollection 2015. Review.

10.

Growth control under stress: mTOR regulation through the REDD1-TSC pathway.

Ellisen LW.

Cell Cycle. 2005 Nov;4(11):1500-02. Epub 2005 Nov 1. Review.

PMID:
16258273
11.

Lymphangioleiomyomatosis: Current understanding and potential treatments.

Moir LM.

Pharmacol Ther. 2016 Feb;158:114-24. doi: 10.1016/j.pharmthera.2015.12.008. Epub 2015 Dec 20. Review.

PMID:
26713679
12.

The role of chemokines in migration of metastatic-like lymphangioleiomyomatosis cells.

Pacheco-Rodriguez G, Moss J.

Crit Rev Immunol. 2010;30(4):387-94. Review.

13.

Lymphangioleiomyomatosis - a wolf in sheep's clothing.

Henske EP, McCormack FX.

J Clin Invest. 2012 Nov;122(11):3807-16. doi: 10.1172/JCI58709. Epub 2012 Nov 1. Review.

14.

[Pulmonary lymphangioleiomyomatosis: From pathogenesis to management].

Chebib N, Khouatra C, Lazor R, Archer F, Leroux C, Gamondes D, Thivolet-Bejui F, Cordier JF, Cottin V.

Rev Mal Respir. 2015 Nov 18. pii: S0761-8425(15)00369-1. doi: 10.1016/j.rmr.2015.10.005. [Epub ahead of print] Review. French.

PMID:
26604019
15.

Management of lymphangioleiomyomatosis.

Taveira-DaSilva AM, Moss J.

F1000Prime Rep. 2014 Dec 1;6:116. doi: 10.12703/P6-116. eCollection 2014. Review.

16.

The Tsc1-Tsc2 complex influences neuronal polarity by modulating TORC1 activity and SAD levels.

Wildonger J, Jan LY, Jan YN.

Genes Dev. 2008 Sep 15;22(18):2447-53. doi: 10.1101/gad.1724108. Review.

17.

Lymphangioleiomyomatosis: New Treatment Perspectives.

Radzikowska E.

Lung. 2015 Aug;193(4):467-75. doi: 10.1007/s00408-015-9742-6. Epub 2015 May 17. Review.

PMID:
25980593
18.

Lymphangioleiomyomatosis: a disease involving the lymphatic system.

Seyama K, Kumasaka T, Kurihara M, Mitani K, Sato T.

Lymphat Res Biol. 2010 Mar;8(1):21-31. doi: 10.1089/lrb.2009.0018. Review.

PMID:
20235884
19.

Optimizing treatments for lymphangioleiomyomatosis.

Taveira-DaSilva AM, Moss J.

Expert Rev Respir Med. 2012 Jun;6(3):267-76. doi: 10.1586/ers.12.26. Review.

20.

Sex-specific lung diseases: effect of oestrogen on cultured cells and in animal models.

Shim B, Pacheco-Rodriguez G, Kato J, Darling TN, Vaughan M, Moss J.

Eur Respir Rev. 2013 Sep 1;22(129):302-11. doi: 10.1183/09059180.00002813. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk